Fig. 1From: Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stagesThe distribution of CTA and TAA-specific T cell responses in HCC, LC, CHB and HC. CTA and TAA-specific T cell responses specific to AFP (purple), SALL4 (red), MAGE-A3 (grey), MAGE-A1 (orange), NY-ESO-1 (blue) and SSX2 (green) in 58 HCC patients, 15 LC patients, 15 CHB patients and 10 HC controls. The magnitude of T cell response was evaluated with SFU/106 PBMCs in vertical coordinates (y axis), and 98 candidates, including HCC patients, LC patients, CHB patients and Healthy Control (HC), were labelled in horizontal ordinate (x axis)Back to article page